Skip to main content
. 2021 Jun 3;14:229–235. doi: 10.2147/CEG.S308862

Table 1.

Characteristics of the Patients With and Without Liver Cirrhosis

Cirrhosis (n = 48) No Cirrhosis (n = 478) p value
Demog2raphics
Age, years – mean (±SD) 58.94 (±11.01) 57.60 (±15.79) 0.567
0.031
Male Gender – n (%) 19 (39.58) 267 (55.86)
Ethnicity – n (%) 0.269
 Hispanic 25 (52.08) 253 (52.93)
 African American 12 (25.00) 148 (30.96)
 Caucasian 7 (14.58) 33 (06.90)
 Others 4 (08.33) 44 (09.21)
Associated comorbidities – n (%)
 Hypertension 38 (79.17) 337 (70.65) 0.213
 Diabetes mellitus 26 (54.17) 262 (54.9) 0.92
 ESRD 5 (10.42) 63 (13.21) 0.583
 CHF 11 (22.92) 156 (32.70) 0.165
Presence of other infections – n (%)
 Sepsis 21 (43.75) 233 (48.85) 0.501
 Pneumonia 25 (52.08) 281 (58.91) 0.361
 Urinary tract infection 15 (31.25) 145 (30.40) 0.903
Laboratory parameters – mean (±SD)
 WBC, k/ul 17.61 (±14.20) 15.73 (±/-9.52) 0.222
 Serum Albumin, g/dL 3.46(+0.85) 2.8(+0.7) 0.001
 BUN, mg/dl 41.88 (±29.51) 36.09 (±33.14) 0.246
 Serum Creatinine, mg/dl* 1.1(3) 1.75(3.3) 0.273
 Serum Potassium, mEq/L 3.26 (±0.63) 3.36 (±0.71) 0.374
 Serum Chloride, mEq/L 92.07 (±15.39) 95.25 (±8.76) 0.029
 Serum Bicarbonate, mEq/L 15.04 (±5.44) 17.43 (±5.53) 0.005
 Lactate, mmoles/L* 2(±2) 3.17 (±3.63) 0.22
Outcome
 Mortality – n (%) 19(39.6%) 2.7(3) 0.15
 Length of Stay, days – median (IQR)* 2 (6) 2(5) 0.0806

Notes: The above data is being presented using n (%) and mean ± standard deviation; *Continuous variable represented with Median (interquartile range) and comparison is made with the Mann–Whitney U-test.

Abbreviations: ESRD, end-stage renal disease; CHF, congestive heart failure; WBC, white blood cell; BUN, blood urea nitrogen.